<- Go Home
Evofem Biosciences, Inc.
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. The company’s commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Market Cap
$994.0K
Volume
344.1K
Cash and Equivalents
N/A
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
75.52%
52 Week High
$0.02
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-0.01
Price / Earnings
-0.06
Price / Tangible Book Value
-0.01
Enterprise Value
$60.2M
Enterprise Value / EBITDA
-14.05
Operating Income
N/A
Return on Equity
20.75%
Return on Assets
-26.79
Cash and Short Term Investments
$144.0K
Debt
N/A
Equity
N/A
Revenue
N/A
Unlevered FCF
$8.1M
Sector
Pharmaceuticals
Category
N/A